January 12, 2026 · Form 4 insider transaction
Glover Stephen C. bought 54,876 shares of PDS BIOTECHNOLOGY CORP at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 50 days after the transaction.
The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.